Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/13/2003EP1333862A2 Methods of and pharmaceutical compositions for improving implantation of embryos
08/13/2003EP1333861A2 Using heat shock proteins to increase immune response
08/13/2003EP1333860A1 Antibodies to the propeptide of candida albicans and methods of use
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333855A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
08/13/2003EP1333854A1 The use of bacterial phage associated lytic enzymes to prevent food poisoning
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333852A2 Agents for reducing graft rejection reactions
08/13/2003EP1333851A1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333849A2 Amyloid precursor protein and app-derived peptides inhibit tumor growth and metastasis
08/13/2003EP1333847A1 Combination preparation of a biological response modidier and an anticancer agent and uses thereof
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333843A2 Compositions and methods for prolonging survival of chilled platelets
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1333823A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
08/13/2003EP1333814A1 Parenterally administrable microparticles
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333799A2 Oral composition providing enhanced tooth stain removal
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1115386B1 Medicament for the treatment of infection
08/13/2003EP1066060B1 Mesenchymal stem cells as immunosuppressants
08/13/2003EP1038532A4 Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive
08/13/2003EP0989859B1 Cns neuroregenerative compositions and methods of use
08/13/2003EP0971948B1 Inhibitors for urokinase receptor
08/13/2003EP0914096B1 Microparticles and their use in wound therapy
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
08/13/2003EP0751774B1 Hypocholesterolemic mercaptoacetylamide disulfide derivatives
08/13/2003EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0556344B1 New insulin-like growth factor binding protein
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003EP0470128B2 Active carbonates of polyalkylene oxides for modification of polypeptides
08/13/2003CN1436305A Hypotensors
08/13/2003CN1436304A Method and apparatus for monitoring anti-platelet agent
08/13/2003CN1436246A Method for preparing physiologically active IL-18 polypeptide
08/13/2003CN1436241A Sphingosine kinase and uses thereof
08/13/2003CN1436239A Novel enzyme gene and its expression product
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1436233A Methods and compositions based on VEGF antisense oligonucleotides
08/13/2003CN1436197A Novel compounds of N-acylamino-amide family, compositions comprising same and uses
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436085A Method for treating pain by peripheral administration of neurotoxin
08/13/2003CN1436082A 3'-or 2'-hydroxymethyl substd. nucleoside derivs. for treatment of hepatitis virus infections
08/13/2003CN1436072A Composition, kits, and methods for promoting defined health benefits
08/13/2003CN1435431A Polypeptides matter, method for preparing same and use thereof
08/13/2003CN1435427A Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use
08/13/2003CN1435258A Recombinant human granulocyte-macrophage colony stimulating factor gel
08/13/2003CN1435257A Epidermal mucosa disinfectant contg. recombinant human epidermal growth factor
08/13/2003CN1435256A Oral collagen Ôàí film preparation
08/13/2003CN1117763C Anti-alphaV-integrin monoclonal antibody
08/13/2003CN1117762C Spray dried erythropoietin
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/13/2003CN1117585C Nisin in combination with glycerol monolaurate active against helicobacterium
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/12/2003US6605703 Deletion of the Hck binding region in the IL-6 receptor
08/12/2003US6605702 Protein for use in the treatment of inflammatory defects and asthma
08/12/2003US6605699 Diagnosing cancer, inflammation, and autoimmune diseases
08/12/2003US6605698 Antifungal peptides and composition thereof
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605608 Amino acid derivatives and drugs containing the same as the active ingredient
08/12/2003US6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
08/12/2003US6605594 Aqueous glycerol formulations of somatotropin
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605591 Treatment of subnormal bone mineral density
08/12/2003US6605589 Cathepsin inhibitors in cancer treatment
08/12/2003US6605588 Amino acid sequence of SEQ ID NO:6
08/12/2003US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605449 Saturation mutagenesis to produce progenitor polynucleotide library
08/12/2003US6605448 Filamentous bacteriophage with genetically engineered insert of oligonucleotide population; vectors; gene expression
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605442 Methods of testing drugs or agents that modulate the activity of receptor recognition factors
08/12/2003US6605441 Antibodies against fibroblast growth factor 11
08/12/2003US6605437 Screening methods for compounds useful for the treatment of body weight disorders, including obesity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605425 Immunogenic determinant for use in the diagnosis of Kaposi's sarcoma
08/12/2003US6605424 Contacting with rhodopsin kinase- or beta adrenergic receptor kinase -containing sample; determination of receptor phosphorylation
08/12/2003US6605310 Calorically dense liquid oral supplement
08/12/2003US6605299 Releasable linkage and compositions containing same
08/12/2003US6605298 Drug delivery
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/12/2003US6605277 Conformation-specific anti-von Willebrand factor antibodies
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003US6605274 Method for in vivo regulation of cardiac muscle contractility
08/12/2003US6605273 Renal cell carcinoma treatment
08/12/2003US6605272 Methods of using zalpha11 ligand
1 ... 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 ... 3163